You just read:

Prometheus Receives New York State Approval for PROMETHEUS® Crohn's Prognostic, the First Serogenetic Test to Predict Risk of Complications From Crohn's Disease

News provided by

Prometheus Laboratories Inc.

Feb 22, 2011, 06:00 ET